U.S. market Open. Closes in 4 hours 2 minutes

BDRX | Biodexa Pharmaceuticals Plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue381.00K699.00K578.00K343.00K674.00K1.94M
Cost of Revenue4.07M5.11M4.65M6.07M7.84M9.36M
Gross Profit-3.69M-4.41M-4.08M-5.72M-7.17M-7.42M
Operating Expenses4.33M4.05M1.99M17.71M3.67M4.39M
Selling, General & Admin4.34M4.54M2.95M4.96M4.16M4.39M
Research & Development4.07M5.11M4.65M16.15M7.84M9.36M
Other Operating Expenses-14.00KN/AN/AN/AN/AN/A
Operating Income-8.01M-8.93M-7.00M-10.67M-11.32M-11.81M
Other Expenses / Income487.00K444.00K892.00K-12.80M395.00K-585.00K
Before Tax Income-7.49M-8.49M-6.11M-23.47M-10.92M-12.40M
Income Tax Expenses-406.00K832.00K646.00K1.28M1.78M2.03M
Net Income-7.08M-7.66M-5.46M-22.19M-9.14M-10.37M
Interest Expenses41.00K53.00K44.00K34.00K97.00KN/A
Basic Shares Outstanding789.62K12.35K10.07K5.36K2.29KN/A
Diluted Shares Outstanding789.62K12.35K10.07K5.36K2.29KN/A
EBITDA-7.65M-8.76M-6.79M-9.57M-10.34M-10.70M
EBITDA Margin-2,007.35%-1,252.50%-1,173.88%-2,790.67%-1,533.53%-552.32%
EBIT-7.44M-6.77M-4.77M-20.87M-7.26M-8.34M
EBIT Margin-1,953.81%-968.67%-825.26%-6,085.71%-1,076.56%-430.13%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙